Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01675778 · ClinicalTrials.gov registry record · Phase 2
Association Between Body Size and Response to Hydromorphone in ED
A Phase 2 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 174
- Enrollment target
NCT01675778 is a Phase 2 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 174 participants.
The verdict
NCT01675778, a Phase 2 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 174 participants
- Enrollment target
Study Summary
Pain is the most common complaint for patients presenting to the emergency department (ED). Inadequate pain relief is also a common problem in ED. Patients' pain perceptions and responses to intravenous opioids vary widely and are influenced by multiple factors. The objective of the current study is to examine the association between total body weight, BMI (body mass index) and clinical response to a fixed dose of intravenous hydromorphone.
Interventions
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01675778
The ClinicalTrials.gov registry entry for NCT01675778 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydromorphone is the first listed.
NCT01675778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01675778 about?
NCT01675778 is a clinical study titled "Association Between Body Size and Response to Hydromorphone in ED". Pain is the most common complaint for patients presenting to the emergency department (ED). Inadequate pain relief is also a common problem in ED. Patients' pain perceptions and responses to intravenous opioids vary widely and are influenced by multiple factors. The objective of the current study is...
What is the current status of trial NCT01675778?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 174 participants. The study started on 2011-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01675778?
The interventions under investigation include: Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT01675778?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.